KushCo Stock Forecast, Price & News

KushCo (OTCMKTS:KSHB) Frequently Asked Questions

Is KushCo a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for KushCo in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" KushCo stock.
View analyst ratings for KushCo or view top-rated stocks.

How has KushCo's stock price been impacted by Coronavirus?

KushCo's stock was trading at $0.8049 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, KSHB shares have decreased by 13.7% and is now trading at $0.6950.
View which stocks have been most impacted by COVID-19.

How were KushCo's earnings last quarter?

KushCo Holdings, Inc. (OTCMKTS:KSHB) issued its quarterly earnings data on Wednesday, July, 7th. The company reported ($0.05) EPS for the quarter, missing analysts' consensus estimates of ($0.04) by $0.01. The firm had revenue of $28.32 million for the quarter, compared to the consensus estimate of $33.81 million. KushCo had a negative trailing twelve-month return on equity of 23.46% and a negative net margin of 21.64%.
View KushCo's earnings history.

What price target have analysts set for KSHB?

1 brokers have issued 1 year price objectives for KushCo's shares. Their forecasts range from $2.00 to $2.00. On average, they anticipate KushCo's share price to reach $2.00 in the next twelve months. This suggests a possible upside of 187.8% from the stock's current price.
View analysts' price targets for KushCo or view top-rated stocks among Wall Street analysts.

Who are KushCo's key executives?

KushCo's management team includes the following people:

• Nicholas Kovacevich, Chairman & Chief Executive Officer
• Rodrigo de Oliveira, Chief Operating Officer
• Stephen Christoffersen, Chief Financial Officer
• Ryan Selewicz, Executive Vice President-Technology
• Brian Stewart, Senior Vice President-Product

Who are some of KushCo's key competitors?

Some companies that are related to KushCo include Innovative Industrial Properties (IIPR), Canopy Growth (WEED), Cronos Group (MJN), CanniMed Therapeutics (CMED), OrganiGram (OGI), GrowGeneration (GRWG), 22nd Century Group (XXII), Emblem (EMC), ICC Labs (ICC), Leaf Mobile (LEAF), Bioventix (BVXP), Maple Leaf Green World (MGW), Net Savings Link (NSAV), Unrivaled Brands (TRTC) and General Cannabis (CANN).
View all of KSHB's competitors.

What other stocks do shareholders of KushCo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other KushCo investors own include (CGC), OrganiGram (OGI), Medical Marijuana (MJNA), Supreme Cannabis (SPRWF), Auxly Cannabis Group (CBWTF), Matinas BioPharma (MTNB), Aurora Cannabis (ACB), MariMed (MRMD), Cannabics Pharmaceuticals (CNBX) and American Cannabis (AMMJ).

What is KushCo's stock symbol?

KushCo trades on the OTCMKTS under the ticker symbol "KSHB."

How do I buy shares of KushCo?

Shares of KSHB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is KushCo's stock price today?

One share of KSHB stock can currently be purchased for approximately $0.70.

How much money does KushCo make?

KushCo has a market capitalization of $110.82 million and generates $113.84 million in revenue each year. The company earns $-77.66 million in net income (profit) each year or ($0.18) on an earnings per share basis.

How many employees does KushCo have?

KushCo employs 109 workers across the globe.

What is KushCo's official website?

The official website for KushCo is www.kushco.com.

Where are KushCo's headquarters?

KushCo is headquartered at 6261 KATELLA AVE SUITE 250, CYPRESS CA, 90630.

How can I contact KushCo?

KushCo's mailing address is 6261 KATELLA AVE SUITE 250, CYPRESS CA, 90630. The company can be reached via phone at (714) 462-4603 or via email at [email protected].